Cravatex has informed that the Board of Directors of the Company at their Meeting held today, which started at 3.45 pm and concluded at 4.50 pm have approved the audited financial results (standalone & consolidated), statement of assets & liabilities (standalone & consolidated) and cash flow statement (standalone & consolidated) for the financial year ended 31 March, 2025 together with Auditors' Report. Further pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statutory Auditors of the Company have issued the Auditors' Report for the financial year ended 31s March, 2025 with unmodified opinion; Recommended a dividend of Rs.12.50 per share (@ 125%) on Equity Shares of Rs 10 each for the financial year ended 31st March, 2025, for approval of the members at the forthcoming Annual General Meeting. The dividend, if approved by the members, shall be paid within the timelines prescribed under the law.
The above information is a part of company’s filings submitted to BSE.
